Uridine triphosphate

N/A

Report date: 2023/01/03 20:00:35
NME

Base Information

Drug NameUridine triphosphate
Drug Alias Name尿啶三磷酸尿苷三磷酸三磷酸尿苷INS-316KRN-316 +[7] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionPurinergic receptor P2Y2 agonists
TargetsPurinergic receptor P2Y2
Therapy Area/IndicationsMandibular InjuriesSensation DisordersLung Diseases, Interstitial +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMerck SeronoKirin Holdings Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesUniversitat Internacional De Catalunya
Inactive CompaniesNational Cancer InstituteMerck Sharp & Dohme LLC
Active IndicationsMandibular InjuriesSensation DisordersRetrognathia +[4] 
Inactive IndicationsLung Diseases, InterstitialLung Neoplasms

Other Information

ATC CodeN/A
Related LinksDrugBank